Investor Alert:
CIRO is issuing a warning to Canadian investors regarding Canada Token Trade.
Effective Date: December 31, 2021
IIROC is publishing this Guidance Note to provide clarification regarding the required practice and acceptable alternative procedures (if applicable) for classifying and documenting trades as resolved for over-the-counter (OTC) trades and financing transactions with U.S. counterparties.
The notes and instructions to Statement B, Line 22, state: “Items are considered unresolved unless: (i) a written acknowledgement from the counterparty of a valid claim has been received; and (ii) a journal entry to resolve the difference has been processed as of the due date of Form 1. This does not include journal entries writing off the difference to profit or loss in the period subsequent to the date of Form 1….”
The reconciliation of certain U.S. counterparty transactions, such as OTC trades and financing transactions provide reporting challenges to Dealer Members (Dealers), as the U.S. counterparty is only required to provide statements not less than once every calendar quarter in accordance with FINRA Rule 22311 . There is no requirement to provide statements on a monthly basis.
The following are acceptable alternatives to the requirements of a month-end statement:
Counterparty |
Required |
Acceptable alternative procedures |
U.S. counterparty |
Monthly statement |
|
Canadian counterparty |
Monthly statement |
|
IIROC Rules this Guidance Note relates to:
This Guidance Note replaces MR0525 - Acceptable Alternative Procedures for U.S. Broker Reconciliations (Statement B, Form 1).
This Guidance Note was published under Notice 21-0190 - IIROC Rules, Form 1 and Guidance.